Leonie Exterkate
Papers
2
Total Citations
23
H-Index
2
About
Leonie Exterkate is a leading researcher in oncological imaging, with a primary focus on improving the detection and staging of prostate cancer. Her work centers on the validation and clinical application of advanced molecular imaging techniques, particularly 18F-PSMA-1007 Positron Emission Tomography/Computed Tomography (PET/CT). Exterkate’s major contribution lies in her rigorous head-to-head comparison of PSMA-PET/CT with multiparametric Magnetic Resonance Imaging (mpMRI), using whole-mount histopathology as the gold standard. This landmark 2023 study, which has garnered 20 citations, demonstrated the superior accuracy of PSMA-PET/CT in localizing and staging primary prostate cancer, challenging existing diagnostic paradigms. She further advanced the field by providing immunohistochemical and histopathological validation of PSMA-PET/CT, confirming that tracer uptake directly correlates with PSMA overexpression in cancerous lesions. This foundational work not only establishes a robust evidence base for integrating PSMA-PET/CT into routine clinical workflows but also paves the way for more precise, personalized treatment planning. Exterkate’s research is instrumental in bridging the gap between advanced imaging and pathological reality, making her a pivotal figure in the evolution of prostate cancer diagnostics.
Research Focus
Key Achievements
Top Papers
- 1
- 2